Literature DB >> 8348310

Elevated concentrations of nerve growth factor in heart and mesenteric arteries of spontaneously hypertensive rats.

C Zettler1, R A Rush.   

Abstract

Considerable evidence indicates an enhanced sympathetic innervation of muscular resistance arteries in the spontaneously hypertensive rat (SHR) compared with its normotensive Wistar-Kyoto (WKY) control. Since nerve growth factor (NGF) is known to affect the growth of sympathetic nerves, we have utilized a sensitive two-site enzyme linked immunoassay for NGF to compare the NGF content of hearts and mesenteric arteries of developing SHR and WKY rats. NGF levels in hearts revealed similar, although not identical, patterns of expression. In both strains, NGF levels declined from postnatal day 15, the earliest age examined, to stabilize at adult levels by postnatal day 32. Adult SHR concentrations were similar to those in age matched WKY controls. In contrast, in the mesenteric vascular bed, NGF levels of SHR were greater than those of WKY controls at all ages above 15 days. Moreover, these changes in NGF occurred concomitantly with increases in vascular mass and medial smooth muscle hyperplasia in the SHR. Whether abnormal NGF levels are a cause or consequence of vascular smooth muscle growth has yet to be determined. These results are consistent with the hypothesis that the hyper-noradrenergic innervation of SHR vascular tissues results from an early elevation of NGF gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348310     DOI: 10.1016/0006-8993(93)91012-h

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  [siRNAs with high specificity to the target: a systematic design by CRM algorithm].

Authors:  T Alsheddi; L Vasin; R Meduri; M Randhawa; G Glazko; A Baranova
Journal:  Mol Biol (Mosk)       Date:  2008 Jan-Feb

2.  Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes.

Authors:  S T Lockhart; G G Turrigiano; S J Birren
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

3.  Nerve sprouting contributes to increased severity of ventricular tachyarrhythmias by upregulating iGluRs in rats with healed myocardial necrotic injury.

Authors:  Jing Lü; Xue Gao; Jingli Gu; Lan Zhou; Shu Guo; Wei Hao; Zhuan Zhou; Ji-Min Cao
Journal:  J Mol Neurosci       Date:  2012-03-02       Impact factor: 3.444

Review 4.  Functional roles of neurotrophin 3 in the developing and mature sympathetic nervous system.

Authors:  X F Zhou; R A Rush
Journal:  Mol Neurobiol       Date:  1996-12       Impact factor: 5.590

5.  Absence of the p75 neurotrophin receptor alters the pattern of sympathosensory sprouting in the trigeminal ganglia of mice overexpressing nerve growth factor.

Authors:  G S Walsh; K M Krol; M D Kawaja
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

6.  Aortic coarctation hypertension induces fibroblast growth factor-2 immunoreactivity in the stimulated nucleus tractus solitarii.

Authors:  Debora Rejane Fior-Chadi; Tatiana Cristina Nogueira Varella; Jessica Ruivo Maximino; Gerson Chadi
Journal:  J Mol Histol       Date:  2007-06-12       Impact factor: 2.611

7.  Hypertrophy of neurons within cardiac ganglia in human, canine, and rat heart failure: the potential role of nerve growth factor.

Authors:  Sanjay Singh; Scott Sayers; James S Walter; Donald Thomas; Robert S Dieter; Lisa M Nee; Robert D Wurster
Journal:  J Am Heart Assoc       Date:  2013-08-19       Impact factor: 5.501

Review 8.  The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections.

Authors:  Andrea László; Lilla Lénárt; Lilla Illésy; Andrea Fekete; János Nemcsik
Journal:  J Neural Transm (Vienna)       Date:  2019-02-14       Impact factor: 3.575

9.  Plasma and Urinary Levels of Nerve Growth Factor Are Elevated in Primary Hypertension.

Authors:  Fumihiro Tomoda; Atsumi Nitta; Hiroko Sugimori; Tsutomu Koike; Koichiro Kinugawa
Journal:  Int J Hypertens       Date:  2022-03-01       Impact factor: 2.420

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.